73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Researchers find superantigen mutant can trigger immune response in ovarian cancer cells

Researchers find superantigen mutant can trigger immune response in ovarian cancer cells

by Liu Jia,Chinese Academy of SciencesThe transwell co-culture models of transcriptome experiment. Credit:International Journal of Molecular Sciences(2023). DOI: 10.3390/ijms24141179

Researchers find superantigen mutant can trigger immune response in ovarian cancer cells

by Liu Jia,Chinese Academy of SciencesThe transwell co-culture models of transcriptome experiment. Credit:International Journal of Molecular Sciences(2023). DOI: 10.3390/ijms24141179
Trial demonstrates firmonertinib is a potential therapy for patients with NSCLC with EGFR PACC mutations

Trial demonstrates firmonertinib is a potential therapy for patients with NSCLC with EGFR PACC mutations

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe tyrosine kinase inhibitor firmonertinib showed promising efficacy in patients with non-small cell lung can

Trial demonstrates firmonertinib is a potential therapy for patients with NSCLC with EGFR PACC mutations

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe tyrosine kinase inhibitor firmonertinib showed promising efficacy in patients with non-small cell lung can
'Exhausted' immune cells in healthy women could be target for breast cancer prevention

'Exhausted' immune cells in healthy women could be target for breast cancer prevention

byUniversity of CambridgeImmune cell exhaustion is observed in breast tissue from carriers of BRCA1 and BRCA2 mutations long before breast cancer develops. Credit: Sara Pensa/University of Cambr

'Exhausted' immune cells in healthy women could be target for breast cancer prevention

byUniversity of CambridgeImmune cell exhaustion is observed in breast tissue from carriers of BRCA1 and BRCA2 mutations long before breast cancer develops. Credit: Sara Pensa/University of Cambr
New study suggests way to predict outcomes with high accuracy prior to surgery for pancreatic cancer patients

New study suggests way to predict outcomes with high accuracy prior to surgery for pancreatic cancer patients

by National Comprehensive Cancer NetworkPancreatic cancer cells (blue) growing as a sphere encased in membranes (red). Credit: National Cancer InstituteNew research in the September 2022 issue of&nbsp

New study suggests way to predict outcomes with high accuracy prior to surgery for pancreatic cancer patients

by National Comprehensive Cancer NetworkPancreatic cancer cells (blue) growing as a sphere encased in membranes (red). Credit: National Cancer InstituteNew research in the September 2022 issue of&nbsp
Researchers identify a promising new drug target for rare liver cancer

Researchers identify a promising new drug target for rare liver cancer

by Rockefeller UniversityCredit: Pixabay/CC0 Public DomainAs a rare and lethal liver cancer that disproportionately harms young adults, fibrolamellar carcinoma is nearly incurable. Surgery can re

Researchers identify a promising new drug target for rare liver cancer

by Rockefeller UniversityCredit: Pixabay/CC0 Public DomainAs a rare and lethal liver cancer that disproportionately harms young adults, fibrolamellar carcinoma is nearly incurable. Surgery can re
Review covers progress in immunotherapy for esophageal cancer

Review covers progress in immunotherapy for esophageal cancer

by Cactus CommunicationsMultiple ongoing clinical trials are being conducted to test the potential of ICIs as an adjuvant therapy for resectable esophageal cancer. The results of these trials could ce

Review covers progress in immunotherapy for esophageal cancer

by Cactus CommunicationsMultiple ongoing clinical trials are being conducted to test the potential of ICIs as an adjuvant therapy for resectable esophageal cancer. The results of these trials could ce
New compounds target and kill brain cancer cells after being energized by low X-ray dose

New compounds target and kill brain cancer cells after being energized by low X-ray dose

by Nanyang Technological UniversityResearch fellow Dr Huang Jingsheng from NTU Singapore's School of Chemistry, Chemical Engineering and Biotechnology preparing new anti-brain cancer compound

New compounds target and kill brain cancer cells after being energized by low X-ray dose

by Nanyang Technological UniversityResearch fellow Dr Huang Jingsheng from NTU Singapore's School of Chemistry, Chemical Engineering and Biotechnology preparing new anti-brain cancer compound
New recommendations developed for breast cancer screening

New recommendations developed for breast cancer screening

(HealthDay)—New recommendations have been developed for breast cancer screening based on a life-years-gained model; the American Society of Breast Surgeons (ASBrS) official statement was published onl

New recommendations developed for breast cancer screening

(HealthDay)—New recommendations have been developed for breast cancer screening based on a life-years-gained model; the American Society of Breast Surgeons (ASBrS) official statement was published onl
Using AI, researchers pioneer a potential new immunotherapy approach for treating glioblastoma

Using AI, researchers pioneer a potential new immunotherapy approach for treating glioblastoma

byKeck School of Medicine of USCGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0In an innovative study of glioblastoma, scientists used artificial intelligence (AI) to reprogram ca

Using AI, researchers pioneer a potential new immunotherapy approach for treating glioblastoma

byKeck School of Medicine of USCGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0In an innovative study of glioblastoma, scientists used artificial intelligence (AI) to reprogram ca
Single-cell analysis reveals how melanoma cells resist immunotherapy

Single-cell analysis reveals how melanoma cells resist immunotherapy

by Karen Zusi,Broad Institute of MIT and HarvardCredit: Broad Institute of MIT and HarvardUnleashing the immune system to fight tumors—an approach enabled by immunotherapy—has led to remarkable

Single-cell analysis reveals how melanoma cells resist immunotherapy

by Karen Zusi,Broad Institute of MIT and HarvardCredit: Broad Institute of MIT and HarvardUnleashing the immune system to fight tumors—an approach enabled by immunotherapy—has led to remarkable
Patient-derived organoids in human cancer: A platform for fundamental research and precision medicine

Patient-derived organoids in human cancer: A platform for fundamental research and precision medicine

by Sichuan International Medical Exchange and Promotion AssociationThe GBM organoids culture process and subsequent analysis are illustrated schematically. A rapid and dependable technique has been de

Patient-derived organoids in human cancer: A platform for fundamental research and precision medicine

by Sichuan International Medical Exchange and Promotion AssociationThe GBM organoids culture process and subsequent analysis are illustrated schematically. A rapid and dependable technique has been de
Researchers unravel novel mechanism by which tumors grow resistant to radiotherapy

Researchers unravel novel mechanism by which tumors grow resistant to radiotherapy

by Ludwig Institute for Cancer ResearchRalph Weichselbaum is the co-director of the Ludwig Center at Chicago. Credit: Ludwig Cancer ResearchA Ludwig Cancer Research study has uncovered a key mech

Researchers unravel novel mechanism by which tumors grow resistant to radiotherapy

by Ludwig Institute for Cancer ResearchRalph Weichselbaum is the co-director of the Ludwig Center at Chicago. Credit: Ludwig Cancer ResearchA Ludwig Cancer Research study has uncovered a key mech